15
Participants
Start Date
March 19, 2021
Primary Completion Date
September 30, 2022
Study Completion Date
September 30, 2022
lorlatinib
Oral
Starship Blood and Cancer Centre, Auckland
Westmead Hospital, Westmead
University of Pennsylvania School of Medicine, Philadelphia
Queen Silvia Children's Hospital, Gothenburg
Seoul National University Bundang Hospital, Seongnam
HRH Crown Princess Victoria's Children and Youth Hospital, Linköping
ST0683AU - Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050 Australia
Instituto Portugues de Oncologia de Lisboa, Lisbon
Samsung Medical Center, Seoul
Karolinska Institutet, Stockholm
Norrland University Hospital, Umeå
Lead Sponsor
Pfizer
INDUSTRY